ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Johnson And Johnson

Johnson And Johnson (JNJ)

138.76
0.62
(0.45%)
Closed 11 January 8:00AM
Realtime Data
Advanced chart

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
138.76
Bid
138.46
Offer
138.86
Volume
13,123
137.72 Day's Range 140.20
132.74 52 Week Range 153.98
Market Cap
Previous Close
138.14
Open
138.06
Last Trade
6
@
138.76
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,192
Shares Outstanding
2,407,622,972
Dividend Yield
3.66%
PE Ratio
9.73
Earnings Per Share (EPS)
14.6
Revenue
85.16B
Net Profit
35.15B

About Johnson And Johnson

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
New Brunswick, New Jersey, USA
Founded
-
Johnson And Johnson is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker JNJ. The last closing price for Johnson And Johnson was 138.14 €. Over the last year, Johnson And Johnson shares have traded in a share price range of 132.74 € to 153.98 €.

Johnson And Johnson currently has 2,407,622,972 shares in issue. The market capitalisation of Johnson And Johnson is 332.59 € billion. Johnson And Johnson has a price to earnings ratio (PE ratio) of 9.73.

JNJ Latest News

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on Tuesday, March 2, 2010, at the New York Palace...

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific...

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was $4.40 Excluding Special Items, 2009 Fourth-Quarter...

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, January 26, 2010, to discuss fourth-quarter and...

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a...

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable...

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic...

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year PHILADELPHIA, Oct. 19 /PRNewswire/ -- New long-term data...

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first...

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13, 2009, to discuss third-quarter financial...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.9-1.35077491824140.66142.54137.3212641138.80392064DE
4-1.2-0.857387825093139.96142.54136.5212169138.95842746DE
12-13.06-8.60229218812151.82153.97999136.529192143.3492115DE
263.12.28512457615135.66153.97999135.528763144.92157002DE
52-9.14-6.17985125085147.9153.97999132.749277142.97919949DE
156-14.74-9.60260586319153.5178.26132.746136148.2183085DE
2607.485.69774527727131.28178.26104.127677139.86785467DE

JNJ - Frequently Asked Questions (FAQ)

What is the current Johnson And Johnson share price?
The current share price of Johnson And Johnson is 138.76 €
How many Johnson And Johnson shares are in issue?
Johnson And Johnson has 2,407,622,972 shares in issue
What is the market cap of Johnson And Johnson?
The market capitalisation of Johnson And Johnson is EUR 332.59B
What is the 1 year trading range for Johnson And Johnson share price?
Johnson And Johnson has traded in the range of 132.74 € to 153.98 € during the past year
What is the PE ratio of Johnson And Johnson?
The price to earnings ratio of Johnson And Johnson is 9.73
What is the cash to sales ratio of Johnson And Johnson?
The cash to sales ratio of Johnson And Johnson is 4.02
What is the reporting currency for Johnson And Johnson?
Johnson And Johnson reports financial results in USD
What is the latest annual turnover for Johnson And Johnson?
The latest annual turnover of Johnson And Johnson is USD 85.16B
What is the latest annual profit for Johnson And Johnson?
The latest annual profit of Johnson And Johnson is USD 35.15B
What is the registered address of Johnson And Johnson?
The registered address for Johnson And Johnson is ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933
What is the Johnson And Johnson website address?
The website address for Johnson And Johnson is www.jnj.com
Which industry sector does Johnson And Johnson operate in?
Johnson And Johnson operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
76M0Realbotix Corp
0.416 €
(80.87%)
1.54M
LT1BVerifyMe Inc
2.70 €
(65.64%)
43.88k
ZK7Conduit Pharmaceuticals Inc
0.129 €
(60.25%)
319.72k
N79Blackbird Critical Metals Corp
0.1549 €
(52.76%)
1.45k
E3O1Nexoptic Technology Corp
0.0285 €
(50.00%)
3.14k
GR2Marvel Gold Limited
0.001 €
(-80.00%)
95.54k
1K0IGM Biosciences Inc
1.90 €
(-62.00%)
596
0PV2Moovly Media Inc
0.002 €
(-55.56%)
1.5k
POTAPortofino Resources Inc
0.0028 €
(-46.15%)
35k
0M4Mersana Therapeutics Inc
0.7058 €
(-44.01%)
144.8k
PF8European Lithium Limited
0.0336 €
(2.44%)
3M
D7GNel ASA
0.2451 €
(-3.50%)
2.56M
LHADeutsche Lufthansa AG
5.656 €
(0.35%)
1.9M
G7PAEnergy Transition Minerals Ltd
0.046 €
(2.22%)
1.81M
RQ0DWave Quantum Inc
5.61 €
(-8.12%)
1.78M

JNJ Financials

Financials

Discussion

View Full Feed
timberwolf7 timberwolf7 5 minutes ago
Gap?? There was about a 2 CENT one on Dec 13-Dec 14 around 26 - 28 cents..

Yeah, you can call it 'filled'
TNXP
ProfitChaser ProfitChaser 6 minutes ago
This one up almost 100% today on big volume for it. Closed at .0071. Hopefully it continues next week. HOD at .0076 today
badshah badshah 6 minutes ago
I meant "comprendez vous?" As in comprende?
RNVA
ddls ddls 6 minutes ago
biwels
BIEL
Steady_T Steady_T 6 minutes ago
I now fear a concerted effort to drive the SP down prior to the presentation and then an AF and the gang hit piece just after the presentation.

The MMs are going to want to close at $10 on Friday. That will take some work to accomplish. At 21.8 million shares short that is about a $24
AVXL
janice shell janice shell 7 minutes ago
Good article!
Jim Beem Jim Beem 7 minutes ago
dumped back into the .0004s as expected
ASII
Ayock Ayock 7 minutes ago
Hi Friends of the Patriotic Millionaires,

Happy New Year! We hope that you and those close to you have had a wonderful start to 2025.

We might be millionaires, but we’re no different than most when it comes to setting New Year’s resolutions. We think goal setting is i
BIOCHEMUP BIOCHEMUP 7 minutes ago
SOUN I dont expert $5. Maybe $8-$9. I would scale in at $10. Check BNRG by the way. The only OTC I hold is RSPI. Also my lottery ticket.
BNRG RSPI SOUN
JonDoe1 JonDoe1 7 minutes ago
They don't have anything to do with the "plant" so who cares. You forgot to hit the bold key again.
AABB
jbog jbog 7 minutes ago
If it doesn't hit RSV it'll be a lot closer to zip than it is today. The hcv drug will have trouble paying down the notes so they'll peak out at a 1,42 multiplier and at todays price they would have to dilute just to live another year.

The Immu program is years away and the spent $2
MVTKL MVTKL 7 minutes ago
https://www.the-sun.com/sport/13239803/boxing-news-don-king-rumble-jungle-2-lawsuit-sued/
MWWC
Gmenfan Gmenfan 8 minutes ago
The brains of the dems sure are different than the sane folks in America! TDS appears to be imbedded in there DNA!

Calif: Democrats Convene Special Session To ‘Trump-Proof’ State During Raging Fires: ‘More Focused On Trump Than Helping Residents’

https://www.oann.com/n
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 8 minutes ago
Madrigal Pharmaceuticals. Went from $66.91 on Dec 5,2022 to over $300 on Dec 19,2022

Yes that would be consistent with the $50 share price we anticipate when this story is fully known in a few months and the application is still on track.
AVXL
doughnuthole doughnuthole 8 minutes ago
Redacted documents in legal proceedings, including those from bankruptcy cases, often remain redacted indefinitely unless a court order or legal process deems that the information can or should be disclosed. This is typically done to protect sensitive information such as trade secrets, financial det
toogoodfella toogoodfella 8 minutes ago
THE POINT IS WHY BOTHER TO BUY SUCH AMOUNT OF DEBT CLAIM FROM A BANKRUPTED COMPANY???

S4 IS ALWAYS OUT OF TUNE.
IT IS SO SIMPLE AS ONE PLUS ONE IS EQUAL TO 10... GET IT??????

LEHNQ
Lord Barek Lord Barek 8 minutes ago
Here is the message in English: "Sorry for the inconvenience. Our website is undergoing scheduled maintenance. Thank you for your understanding."
ATWT
Tdeank1 Tdeank1 9 minutes ago
Wait someone coming on an anonymous message board wanting folks to know how they sold at a high after the stock is tanking is mature...and someone who calls out their BS and need for adoration immature

We are living in bizzaro world
COOP
Tdeank1 Tdeank1 9 minutes ago
Wait someone coming on an anonymous message board wanting folks to know how they sold at a high after the stock is tanking is mature...and someone who calls out their BS and need for adoration immature

We are living in bizzaro world
COOP
Countmein Countmein 9 minutes ago
Closed @ 27.23 on 1,681,457 volume

Count
HOMB
floridaboy floridaboy 9 minutes ago
Company has been growing. Imo, merging a revenue generating company into the mix would be just what the doctor ordered...
MEDH
timberwolf7 timberwolf7 9 minutes ago
OT: on trading the SQQQ or any other BEAR ETF:

2 comments on using them:
-they don't go up as fast as the BULL companion one falls
-they self destruct in price, so if you are going to use them, trade them
actively
This is from personal experience som
SQQQ TNA UVXY
peanutz peanutz 9 minutes ago
There are so many NASDAQ and NYSE good plays . Right situation and you can make better profits than stinky pinky . RSPI is my big lottery pick . Watching for a buyout
RSPI

Your Recent History

Delayed Upgrade Clock